|Wiebke Arlt MD, DSc, FRCP, FMedSci
Institute of Metabolism and Systems Research (IMSR),
University of Birmingham,
UKResearch focus: the role of steroid metabolism in human health and disease, with translational focus on androgen excess and adrenal disease.
|Olaf Dekkers MD, PhD, MSc, MA
Professor of research methodology, Endocrinologist and Epidemiologist, Leiden University Medical Center, Netherlands
Research focus: endocrine diseases, meta-analysis and methodology of research.
Professor, Department of Paediatric Endocrinology and Diabetes, Head, Reference Center for Rare Endocrine Growth Diseases, Robert Debré University Hospital, Paris, France
Her research interests include various aspects of thyroid, pituitary and pubertal diseases management and epidemiology of rare growth endocrine disorders.
Professor of Translational Molecular Medicine, University of Edinburgh, UK
His clinical and research interests are in the role of disordered insulin action in disease, and in mechanisms underpinning adipose tissue resilience and plasticity across the life course. His principal approach is to focus on rare human acquired or monogenic disorders of insulin action. He also has a major interest in somatic mosaic activation of growth signalling pathways.
|Marianne Andersen PhD, DMSci
Professor of Endocrinology, Novo Nordisk foundation, Denmark
Research focus: Pathophysiology and treatment of pituitary diseases (and male hypogonadism).
Professor, Endocrine Department, Cochin Hospital, Paris, France
Specializes in general endocrinology, primarily Cushing syndromes, adrenal tumors, pituitary diseases, as well as thyroid, parathyroid and gonadal diseases.
|Kåre I Birkeland
Professor of Medicine and Senior Endocrinologist, University of Oslo and Oslo University Hospital, Oslo, Norway
His main research interests are Type 2 diabetes, clinical and translational research.
|Cesar Luiz Boguszewski MD, PhD
Regional Editor for South America
Professor of Endocrinology, Endocrine Division (SEMPR), Department of Internal Medicine, Federal University of Parana, Curitiba, Brazil
Research focus: Pituitary diseases, obesity and neuroendocrine body weight regulation.
Regional Editor for North America
Professor, Departments of Orthopedic Surgery and Medicine, University of Connecticut Health Center, Hartford, CT, USA
The Canalis laboratory discovered the existence of skeletal growth factors and his interests centre around growth factors and their antagonists, anabolic agents, and determinants of cell fate, such as Notch.
Head, Department of Endocrinology, Metabolic Diseases and Nutrition, CHU Rangueil-Larrey
His research interests include clinical thyroidology, hypothalamic pituitary diseases, growth disorders and neuroendocrine tumours.
|Hedi Claahsen-van der Grinten
Head, Department of Pediatric Endocrinology, Radboud University Nijmegen Medical Centre, the Netherlands
Her research interests are in adrenal diseases with a special focus on defects of adrenal steroid synthesis. Her research group studies different aspects of congenital adrenal hyperplasia (CAH), and other forms of disorders/differences of sex development (DSD), with emphasis on the role of adrenal steroid precursors and etiology of testicular adrenal rest tumours (TART).
Professor of Medicine at the University of Würzburg, Chairman Division of Endocrinology and Diabetes, University Hospital of Würzburg, Germany
His main research focus is on endocrine tumors with a particular focus on adrenal tumors and adrenal disease in general.
Associate Professor of Endocrinology, Department of Pathophysiology and Transplantation, University of Milan Endocrine Unit, Fondazioen IRCCS Ca’Granda, Milan, Italy
Her main research interests include the molecular basis, clinical and therapeutic aspects of thyroid cancer. Genetics of congenital hypothyroidism.
Regional Editor for Australasia
Emeritus Fellow, The Garvan Institute of Medical Research; Professor of Medicine, University of New South Wales and St. Vincent’s Hospital, Sydney, Australia
Research interests: Pituitary disorders, neuroendocrine regulation of substrate and energy metabolism, endocrinology of sports.
Associate Professor of Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
His main contributions in clinical research are on the syndromes of steroid hormones excess and defect, specifically male hypogonadism, Cushing’s syndrome and adrenal insufficiency.
|Gudmundur Johannsson MD, PhD
Senior Consultant, Department of Endocrinology, Sahlgrenska University Hospital; Professor of Endocrinology, Sahlgrenska Academy, University of Gothenburg, Sweden
His major research interests include pituitary diseases, the importance of growth hormone in adults and adrenal insufficiency.
|Filip K Knop MD, PhD
Consultant Endocrinologist, Professor of Endocrinology and Director of Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Denmark
Professor Knop's resesearch interest centres on the pathophysiology of obesity and its complications including type 2 diabetes and non-alcoholic fatty liver disease, regulation of appetite and food intake, and the therapeutic potential of incretins. He is particularly interested in the integrative role of the gut in human (patho)physiology.
Professor, Department of Medicine, University of Montreal, Canada
Research focus: Molecular mechanisms of adrenal tumors, aberrant hormone receptors in adrenal tumours and hyperplasia, new therapies for pituitary and adrenal tumours.
|Bente L Langdahl
Professor, Consultant, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark
Her research interests include the impact of diabetes on bone health, the effects of vitamins D and K on bone metabolism, and the development of new treatments for osteoporosis.
Niilo Hallman Professor in Translational Pediatrics and Pediatric Endocrinologist at Children's Hospital, University of Helsinki, Helsinki, Finland
His research interest is in pediatric endocrinology with a special focus on mechanisms regulating growth and puberty.
|Abd Tahrani FRCP, MD, PhD
Senior Lecturer in Metabolic Endocrinology and Obesity Medicine, University of Birmingham, UK
His research interests are the metabolic and vascular effects of sleep disorders, obesity, pathogenesis, management and health care delivery, diabetes-related neuropathy (peripheral and autonomic) and the pharmacology of obesity and Type 2 diabetes.
|Jeremy W Tomlinson FRCP, PhD
Professor of Metabolic Endocrinology and Consultant Endocrinologist, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, UK
His research focus is obesity, insulin resistance and steroid hormones.
|Jenny Tong MD, MPH
Associate Professor, Division of Endocrinology, Duke Molecular and Physiology Institute, Duke University, USA
Her primary research interest is the regulation of glucose homeostasis and abnormalities that lead to type 2 diabetes. Work in her lab is directed at understanding the role of gut hormone ghrelin in the regulation of glucose metabolism and food intake using a translational approach.
Consultant Endocrinologist, Erasmus Medical Centre, Rotterdam, Netherlands
His clinical and research interests are thyroid hormone signaling disorders.
|Zhengpei Zeng MD
Regional Editor for China
Professor of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences (CAMS), Beijing, China
Professor Zeng is Honorary President of the Chinese Society of Endocrinology. Her clinical research interests include endocrine hypertension, pheochromocytoma, multiple endocrine neoplasia and adrenal diseases.
|Corinne Alberti MD, PhD
Professor of Epidemiology, Director of the Clinical Epidemiology Unit, Robert Debré Pediatric Teaching Hospital, University of Paris Diderot - Sorbonne Paris Cité, Assistance Publique des Hopitaux de Paris (AP-HP), Director of the CIE 5, Inserm, Paris, France
Her research focuses on clinical epidemiology in pediatrics.
|Mathieu Molimard MD, PhD
Professor of Clinical Pharmacology at University of Bordeaux, Head of the Pharmacology départment University Hospital of Bordeaux, France
His current research focuses on pharmacology of targeted therapies.
|Peter Nightingale BSc, PhD
Statistician, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
He has been Statistician for the Wellcome Trust Clinical Research Facility, Birmingham, since 2001 and provides statistical support to University Hospitals Birmingham and to Dudley Group of Hospitals.
Editors' declarations are listed in the journal's Disclosure Policy.